UPDATE 1-Merck to develop biosimilars with Parexel
January 12, 2011 at 07:56 AM EST
NEW YORK, Jan 12 (Reuters) - Merck & Co struck an alliance with contract researcher Parexel International Corp to develop copies of biotech medicines, deepening the U.S. drugmaker's investment in so-called biosimilar medicines.